cagrisema vs semaglutide in Adults With or Without Diabetes β REDEFINE 1 & 2 β’ π Cagrilintide 2.4 mg + 2.4 mg once weekly β’ π β20.4% weight loss (non-diabetic) & β13.7% (T2D) CagriSema vs Tirzepatide: Weight Loss
Description
The intensity of appetite rebound varies based on how long you took the medication, your genetic predisposition to hunger signaling, and whether you developed sustainable eating habits during treatment
Real screens GLPzy screenshots Clear dashboards for the whole journey Insights keeps weight change, goal distance, BMI, schedule coverage, symptoms, and recap cards readable so progress stays obvious without digging

Ozempic and Wegovy (brand names for semaglutide) are FDA-approved for weight management

In patients with obesity but without type 2 diabetes, semaglutide facilitates about 15% to 16% loss of body weight in a year, Maselli says
Providers rely on medical evidence

& Ng, C
